Cronos Group (CRON)
(Delayed Data from NSDQ)
$2.93 USD
+0.16 (5.78%)
Updated May 13, 2024 04:00 PM ET
After-Market: $2.94 +0.01 (0.34%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRON 2.93 +0.16(5.78%)
Will CRON be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CRON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRON
Cronos Group (CRON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains?
CRON: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Cannabis Stocks Soaring on HHS' Recommendation to DEA
Pacira (PCRX) Lags Q2 Earnings and Revenue Estimates
5 Top-Performing ETFs of Last Week
Other News for CRON
The 7 Most Undervalued Cannabis Stocks to Buy in May 2024
Canadian Cannabis LPs Portfolio Went Down 7% Last Week
Cronos Q1 Financial Metrics Show Improvement; Stock Climbs 3%
Cronos Group Inc (CRON) Surpasses Analyst Revenue Forecasts in Q1 2024
Cronos Group price target raised by C$0.50 at Canaccord